Cargando…

FKBP51 increases the tumour-promoter potential of TGF-beta

BACKGROUND: FKBP51 (FKBP5 Official Symbol) is a large molecular weight component of the family of FK506 binding proteins (FKBP). In recent years, research studies from our laboratory highlighted functions for FKBP51 in the control of apoptosis and melanoma progression. FKBP51 expression correlated w...

Descripción completa

Detalles Bibliográficos
Autores principales: Romano, Simona, D’Angelillo, Anna, D’Arrigo, Paolo, Staibano, Stefania, Greco, Adelaide, Brunetti, Arturo, Scalvenzi, Massimiliano, Bisogni, Rita, Scala, Iris, Romano, Maria Fiammetta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3906759/
https://www.ncbi.nlm.nih.gov/pubmed/24460977
http://dx.doi.org/10.1186/2001-1326-3-1
_version_ 1782301517712195584
author Romano, Simona
D’Angelillo, Anna
D’Arrigo, Paolo
Staibano, Stefania
Greco, Adelaide
Brunetti, Arturo
Scalvenzi, Massimiliano
Bisogni, Rita
Scala, Iris
Romano, Maria Fiammetta
author_facet Romano, Simona
D’Angelillo, Anna
D’Arrigo, Paolo
Staibano, Stefania
Greco, Adelaide
Brunetti, Arturo
Scalvenzi, Massimiliano
Bisogni, Rita
Scala, Iris
Romano, Maria Fiammetta
author_sort Romano, Simona
collection PubMed
description BACKGROUND: FKBP51 (FKBP5 Official Symbol) is a large molecular weight component of the family of FK506 binding proteins (FKBP). In recent years, research studies from our laboratory highlighted functions for FKBP51 in the control of apoptosis and melanoma progression. FKBP51 expression correlated with the invasiveness and aggressiveness of melanoma. Since a role for TGF-β in the enhanced tumorigenic potential of melanoma cells is widely described, we hypothesized a cooperative effect between FKBP51 and TGF-β in melanoma progression. METHODS: SAN and A375 melanoma cell lines were utilized for this study. Balb/c IL2γ NOD SCID served to assess the ability to colonize organs and metastasize of different cell lines, which was evaluated by in vivo imaging. Realtime PCR and western blot served for measurement of mRNA and protein expression, respectively. RESULTS: By comparing the metastatic potential of two melanoma cell lines, namely A375 and SAN, we confirmed that an increased capability to colonize murine organs was associated with increased levels of FKBP51. A375 melanoma cell line expressed FKBP51 mRNA levels 30-fold higher in comparison to the SAN mRNA level and appeared more aggressive than SAN melanoma cell line in an experimental metastasis model. In addition, A375 expressed, more abundantly than SAN, the TGF-β and the pro angiogenic TGF-β receptor type III (TβRIII) factors. FKBP51 silencing produced a reduction of TGF-β and TβRIII gene expression in A375 cell line, in accordance with previous studies. We found that the inducing effect of TGF-β on Sparc and Vimentin expression was impaired in condition of FKBP51 depletion, suggesting that FKBP51 is an important cofactor in the TGF-β signal. Such a hypothesis was supported by co immunoprecipitation assays, showing that FKBP51 interacted with either Smad2,3 and p300. In normal melanocytes, FKBP51 potentiated the effect of TGF-β on N-cadherin expression and conferred a mesenchymal-like morphology to such round-shaped cells. CONCLUSIONS: Overall, our findings show that FKBP51 enhances some pro oncogenic functions of TGF-β, suggesting that FKBP51-overexpression may help melanoma to take advantage of the tumor promoting activities of the cytokine.
format Online
Article
Text
id pubmed-3906759
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Springer
record_format MEDLINE/PubMed
spelling pubmed-39067592014-02-07 FKBP51 increases the tumour-promoter potential of TGF-beta Romano, Simona D’Angelillo, Anna D’Arrigo, Paolo Staibano, Stefania Greco, Adelaide Brunetti, Arturo Scalvenzi, Massimiliano Bisogni, Rita Scala, Iris Romano, Maria Fiammetta Clin Transl Med Research BACKGROUND: FKBP51 (FKBP5 Official Symbol) is a large molecular weight component of the family of FK506 binding proteins (FKBP). In recent years, research studies from our laboratory highlighted functions for FKBP51 in the control of apoptosis and melanoma progression. FKBP51 expression correlated with the invasiveness and aggressiveness of melanoma. Since a role for TGF-β in the enhanced tumorigenic potential of melanoma cells is widely described, we hypothesized a cooperative effect between FKBP51 and TGF-β in melanoma progression. METHODS: SAN and A375 melanoma cell lines were utilized for this study. Balb/c IL2γ NOD SCID served to assess the ability to colonize organs and metastasize of different cell lines, which was evaluated by in vivo imaging. Realtime PCR and western blot served for measurement of mRNA and protein expression, respectively. RESULTS: By comparing the metastatic potential of two melanoma cell lines, namely A375 and SAN, we confirmed that an increased capability to colonize murine organs was associated with increased levels of FKBP51. A375 melanoma cell line expressed FKBP51 mRNA levels 30-fold higher in comparison to the SAN mRNA level and appeared more aggressive than SAN melanoma cell line in an experimental metastasis model. In addition, A375 expressed, more abundantly than SAN, the TGF-β and the pro angiogenic TGF-β receptor type III (TβRIII) factors. FKBP51 silencing produced a reduction of TGF-β and TβRIII gene expression in A375 cell line, in accordance with previous studies. We found that the inducing effect of TGF-β on Sparc and Vimentin expression was impaired in condition of FKBP51 depletion, suggesting that FKBP51 is an important cofactor in the TGF-β signal. Such a hypothesis was supported by co immunoprecipitation assays, showing that FKBP51 interacted with either Smad2,3 and p300. In normal melanocytes, FKBP51 potentiated the effect of TGF-β on N-cadherin expression and conferred a mesenchymal-like morphology to such round-shaped cells. CONCLUSIONS: Overall, our findings show that FKBP51 enhances some pro oncogenic functions of TGF-β, suggesting that FKBP51-overexpression may help melanoma to take advantage of the tumor promoting activities of the cytokine. Springer 2014-01-27 /pmc/articles/PMC3906759/ /pubmed/24460977 http://dx.doi.org/10.1186/2001-1326-3-1 Text en Copyright © 2014 Romano et al.; licensee Springer. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Romano, Simona
D’Angelillo, Anna
D’Arrigo, Paolo
Staibano, Stefania
Greco, Adelaide
Brunetti, Arturo
Scalvenzi, Massimiliano
Bisogni, Rita
Scala, Iris
Romano, Maria Fiammetta
FKBP51 increases the tumour-promoter potential of TGF-beta
title FKBP51 increases the tumour-promoter potential of TGF-beta
title_full FKBP51 increases the tumour-promoter potential of TGF-beta
title_fullStr FKBP51 increases the tumour-promoter potential of TGF-beta
title_full_unstemmed FKBP51 increases the tumour-promoter potential of TGF-beta
title_short FKBP51 increases the tumour-promoter potential of TGF-beta
title_sort fkbp51 increases the tumour-promoter potential of tgf-beta
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3906759/
https://www.ncbi.nlm.nih.gov/pubmed/24460977
http://dx.doi.org/10.1186/2001-1326-3-1
work_keys_str_mv AT romanosimona fkbp51increasesthetumourpromoterpotentialoftgfbeta
AT dangelilloanna fkbp51increasesthetumourpromoterpotentialoftgfbeta
AT darrigopaolo fkbp51increasesthetumourpromoterpotentialoftgfbeta
AT staibanostefania fkbp51increasesthetumourpromoterpotentialoftgfbeta
AT grecoadelaide fkbp51increasesthetumourpromoterpotentialoftgfbeta
AT brunettiarturo fkbp51increasesthetumourpromoterpotentialoftgfbeta
AT scalvenzimassimiliano fkbp51increasesthetumourpromoterpotentialoftgfbeta
AT bisognirita fkbp51increasesthetumourpromoterpotentialoftgfbeta
AT scalairis fkbp51increasesthetumourpromoterpotentialoftgfbeta
AT romanomariafiammetta fkbp51increasesthetumourpromoterpotentialoftgfbeta